Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr. Vice Pres., CFO | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 12,956 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 228 · Balance 12,956 F1: 228 shares were withheld from the 783 restricted shares that vested on October 1, 2026. These 228 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 783 ordinary shares were awarded to Ms. Burton on October 1, 2025. These vested shares were valued at the NYSE closing market price on October 1, 2026. F2: As of October 2, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: 228 shares were withheld from the 783 restricted shares that vested on October 1, 2026. These 228 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 783 ordinary shares were awarded to Ms. Burton on October 1, 2025. These vested shares were valued at the NYSE closing market price on October 1, 2026.
F2: As of October 2, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 8,404 · Balance 0 F1: 7,016 of these ordinary shares are restricted and vest as follows: 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; and 1,332 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.09 · Expires 2021-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,800 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,800 ordinary shares of STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.94 · Expires 2022-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 3,700 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,700 ordinary shares of STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 4,040 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,040 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 3,400 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,400 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.15 · Expires 2025-05-28 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 2,852 · Balance 0 F7: This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,852 ordinary shares of STERIS for $66.15 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 2,600 · Balance 0 F8: This option becomes exercisable as follows: 650 on June 1, 2017, 650 on June 1, 2018, 650 on June 3, 2019 and 650 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,600 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-28 · Disposition to issuer · Disposed 4,000 · Balance 0 F9: This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-28 · Disposition to issuer · Disposed 7,900 · Balance 0 F10: This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,900 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 7,016 of these ordinary shares are restricted and vest as follows: 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; and 1,332 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,800 ordinary shares of STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,700 ordinary shares of STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,040 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,400 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 713 on May 28, 2016, 713 on May 30, 2017, 713 on May 29, 2018 and 713 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,852 ordinary shares of STERIS for $66.15 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 650 on June 1, 2017, 650 on June 1, 2018, 650 on June 3, 2019 and 650 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,600 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F9: This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F10: This option becomes exercisable as follows: 1,975 on May 31, 2019; 1,975 on June 1, 2020; 1,975 on June 1, 2021 and 1,975 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,900 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2018 Filed Feb 14, 2018 16:54 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $31.87 | $0.00 |
DisclosureSEC source: 0001209191-18-009977 · doc4.xml · derivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Ordinary Shares · 1,500 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted on May 20, 2010 and is fully vested. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 16:54 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 1,500 | $85.59 | $128,385.00 |
DisclosureSEC source: 0001209191-18-009977 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,537 F2 · shares: Of the total shares sold, all 1,500 shares were sold pursuant to the above-referenced 10b5-1 plan sale. F3 · balance_after: 7,656 of these shares are restricted and vest as follows: 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020 and 3,000 on June 1, 2021. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 16:54 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 1,500 | $31.87 | $47,805.00 |
DisclosureSEC source: 0001209191-18-009977 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of 1,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 5, 2016. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:29 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $31.87 | $0.00 |
DisclosureSEC source: 0001209191-17-049393 · doc4.xml · derivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Ordinary Shares · 500 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted on May 20, 2010 and is fully vested. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:29 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 3,270 | $85.70 | $280,239.00 |
DisclosureSEC source: 0001209191-17-049393 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,537 F2 · shares: Of the total shares sold, 500 shares were sold pursuant to the above-referenced 10b5-1 plan sale. F3 · balance_after: 7,656 of these shares are restricted and vest as follows: 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020 and 3,000 on June 1, 2021. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:29 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 500 | $31.87 | $15,935.00 |
DisclosureSEC source: 0001209191-17-049393 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of 500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 5, 2016. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:34 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 419 | $77.56 | $32,497.64 |
DisclosureSEC source: 0001209191-17-036798 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,307 F2 · shares: 419 shares were withheld from the 1,300 restricted shares that vested on May 31, 2017. These 419 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,300 ordinary shares were awarded to Ms. Burton on May 31, 2013. These vested shares were valued at the NYSE closing market price on May 31, 2017. F3 · balance_after: 7,656 of these shares are restricted and vest as follows: 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019; 1,220 on June 1, 2020 and 3,000 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:34 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-17-036798 · doc4.xml · derivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 4,000 shares Expires 2027-05-30 F5 · derivative.exercise_date: This option becomes exercisable as follows: 1,000 on May 30, 2018; 1,000 on May 30, 2019; 1,000 on June 1, 2020 and 1,000 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:34 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036798 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,726 F1 · shares: All 3,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on June 1, 2021. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $31.87 | $0.00 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · derivative · entry 7 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300 Underlying: Ordinary Shares · 500 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted on May 20, 2010 and is fully vested. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 475 | $0.00 Strike: $30.84 | $0.00 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · derivative · entry 6 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 475 shares Expires 2018-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted as part of an award of 2,100 ordinary shares, 1,625 of which have previously been exercised. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 0.10 par value | 500 | $67.69 | $33,845.00 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · nonDerivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,726 F2 · balance_after: 5,956 of these shares are restricted and vest as follows: 1,300 on May 31, 2017; 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019 and 1,220 on June 1, 2020. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 0.10 par value | 500 | $31.87 | $15,935.00 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · nonDerivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 975 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 5, 2016. F2 · balance_after: 5,956 of these shares are restricted and vest as follows: 1,300 on May 31, 2017; 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019 and 1,220 on June 1, 2020. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 0.10 par value | 475 | $67.69 | $32,152.75 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,726 F2 · balance_after: 5,956 of these shares are restricted and vest as follows: 1,300 on May 31, 2017; 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019 and 1,220 on June 1, 2020. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 16:57 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 0.10 par value | 475 | $30.84 | $14,649.00 |
DisclosureSEC source: 0001209191-17-011530 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 975 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on December 5, 2016. F2 · balance_after: 5,956 of these shares are restricted and vest as follows: 1,300 on May 31, 2017; 1,000 on April 2, 2018; 972 on May 30, 2018; 764 on May 28, 2019; 700 on October 1, 2019 and 1,220 on June 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.